These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22527647)

  • 21. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
    Schnider P; Moraru E; Kittler H; Binder M; Kranz G; Voller B; Auff E
    Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmenopausal craniofacial hyperhidrosis treated with botulinum toxin type B.
    Cabreus P; Swartling C; Rystedt A
    J Dermatol; 2019 Oct; 46(10):874-878. PubMed ID: 31373068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study.
    Saadia D; Voustianiouk A; Wang AK; Kaufmann H
    Neurology; 2001 Dec; 57(11):2095-9. PubMed ID: 11739832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical botulinum toxin to treat hyperhidrosis? No sweat!
    Lim EC; Seet RC; Chow A; Oh VM; Ong BK; Wilder-Smith EP
    Med Hypotheses; 2006; 67(1):27-32. PubMed ID: 16524669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval.
    Wollina U; Karamfilov T; Konrad H
    J Am Acad Dermatol; 2002 Apr; 46(4):536-40. PubMed ID: 11907503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic effectiveness of botulinum toxin type A based on severity of palmar hyperhidrosis.
    Ito K; Yanagishita T; Ohshima Y; Tamada Y; Watanabe D
    J Dermatol; 2011 Sep; 38(9):859-63. PubMed ID: 21545498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective local anesthesia for onabotulinumtoxin A injections to treat hyperhidrosis associated with traumatic amputation.
    Shi LL; Sargen MR; Chen SC; Arbiser JL; Pollack BP
    Dermatol Online J; 2016 Jun; 22(6):. PubMed ID: 27617615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing residual limb hyperhidrosis in wounded warriors.
    Pace S; Kentosh J
    Cutis; 2016 Jun; 97(6):401-3. PubMed ID: 27416083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term treatment of phantom- and stump pain with Botulinum toxin type A over 12 months. A first clinical observation].
    Kern U; Martin C; Scheicher S; Müller H
    Nervenarzt; 2004 Apr; 75(4):336-40. PubMed ID: 15176410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phantom pain, residual limb pain, and back pain in amputees: results of a national survey.
    Ephraim PL; Wegener ST; MacKenzie EJ; Dillingham TR; Pezzin LE
    Arch Phys Med Rehabil; 2005 Oct; 86(10):1910-9. PubMed ID: 16213230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of botulinum toxin type B for the treatment of primary palmar hyperhidrosis: a prospective, open, single-blind, multi-centre study.
    Basciani M; Di Rienzo F; Bizzarrini M; Zanchi M; Copetti M; Intiso D
    Arch Dermatol Res; 2014 Jul; 306(5):497-503. PubMed ID: 24522897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical utility of botulinum toxin type A local injection therapy for head and forehead hyperhidrosis.
    Ando Y; Ohshima Y; Yanagishita T; Watanabe H; Tamada Y; Akiyama M; Watanabe D
    J Dermatol; 2022 Jul; 49(7):719-723. PubMed ID: 35393718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.
    Naumann MK; Hamm H; Lowe NJ;
    Br J Dermatol; 2002 Dec; 147(6):1218-26. PubMed ID: 12452874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin A treatment for hyperhidrosis in patients with prosthetic limbs.
    Gratrix M; Hivnor C
    Arch Dermatol; 2010 Nov; 146(11):1314-5. PubMed ID: 21079082
    [No Abstract]   [Full Text] [Related]  

  • 37. Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Mallin K; Charles C; Martin LK; Black L; Bryde J
    Dermatol Surg; 2005 Mar; 31(3):263-70. PubMed ID: 15841624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of botulinum toxin A injection for the treatment of secondary axillary bromhidrosis.
    He J; Wang T; Dong J
    J Plast Reconstr Aesthet Surg; 2017 Nov; 70(11):1641-1645. PubMed ID: 28754234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperhidrosis of the residual limb: a narrative review of the measurement and treatment of excess perspiration affecting individuals with amputation.
    Lannan FM; Powell J; Kim GM; Hansen CR; Pasquina PF; Smith DG
    Prosthet Orthot Int; 2021 Dec; 45(6):477-486. PubMed ID: 34723907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hyperhidrosis with botulinum toxin.
    Doft MA; Hardy KL; Ascherman JA
    Aesthet Surg J; 2012 Feb; 32(2):238-44. PubMed ID: 22328694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.